Real-world outcome of patients with advanced renal cell carcinoma and intermediate-or poor-risk international metastatic renal cell carcinoma database consortium …

M Santoni, S Buti, ZW Myint, M Maruzzo… - European urology …, 2024 - Elsevier
Background Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …
被引用次数：10 相关文章

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk International Metastatic Renal Cell Carcinoma Database …

M Santoni, S Buti, ZW Myint… - European urology …, 2024 - nchr.elsevierpure.com
BACKGROUND: Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk International Metastatic Renal Cell Carcinoma Database …

M Santoni, S Buti, Z Myint, M Maruzzo… - EUROPEAN …, 2023 - iris.unipa.it
Background: Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk International Metastatic Renal Cell Carcinoma Database …

M Santoni, S Buti, ZW Myint… - European …, 2024 - euoncology.europeanurology.com
Background Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk International Metastatic Renal Cell Carcinoma Database …

M Santoni, S Buti, ZW Myint, M Maruzzo… - European Urology …, 2023 - europepmc.org
Background Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk International Metastatic Renal Cell Carcinoma Database …

M Santoni, S Buti, ZW Myint, M Maruzzo… - European Urology …, 2024 - researchportal.tuni.fi
BACKGROUND: Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk International Metastatic Renal Cell Carcinoma Database …

M Santoni, S Buti, ZW Myint, M Maruzzo… - EUROPEAN …, 2024 - iris.univpm.it
Background: Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk International Metastatic Renal Cell Carcinoma Database …

M Santoni, S Buti, ZW Myint, M Maruzzo… - EUROPEAN …, 2024 - iris.uniroma1.it
Background: Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk International Metastatic Renal Cell Carcinoma Database …

M Santoni, S Buti, ZW Myint, M Maruzzo… - EUROPEAN …, 2024 - flore.unifi.it
Background: Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk International Metastatic Renal Cell Carcinoma Database …

M Santoni, S Buti, ZW Myint, M Maruzzo… - EUROPEAN …, 2023 - air.unipr.it
Background: Renal c carcinoma (RCC) is one of the most common urinary cancers
worldwide, with a predicted increase in incidence in the coming years. Immunotherapy, as a …